Skip to main content
. 2021 Jun 16;1:1. [Version 2] doi: 10.3310/nihropenres.13217.1

Table 5. Post-operative outcomes for low, medium, high and highest risk groups categorised by pre-chemotherapy/chemoradiotherapy oxygen uptake at anaerobic threshold (ml.kg -1.min -1).

Low (n=21) Medium (n=39) High (n=38) Highest (n=11)
Post-Operative Morbidity Survey (POMS)
Day 3 a 20 (95.2%) 31 (79.5%) 33 (86.8%) 10 (90.9%)
Day 5 b 20 (95.2%) 30 (76.9%) 26 (68.4%) 7 (63.6%)
Day 8 c 5 (23.8%) 21 (53.8%) 20 (52.6%) 5 (45.5%)
Day 15 d 4 (19.0%) 7 (17.9%) 5 (13.2%) 1 (9.1%)
Length of Stay (days) a 12 (9-15) 13 (10-18) 11 (9-14.5) 13.5 (7-16)
O-POSSUM Physiology score a 16.4 (3.3) 17.0 (3.4) 17.7 (2.9) 17.4 (2.8)
O-POSSUM Mortality score a 7.8 (4.9) 10.0 (6.0) 12.6 (6.7) 11.5 (5.0)
RCRI (total score) a 1.0 (0.2) 1.1 (0.4) 1.2 (0.5) 1.5 (0.8)
Level 2/3 Length of Stay a 4 (3-7) 4 (3-5) 4 (2-6) 4 (3-5)
Discharge Destination
Home 20 (95.2%) 39 (100%) 30 (78.9%) 5 (45.5%)
Intermediate care 0 (0%) 0 (0%) 5(13.1%) 3 (9.1%)
Nursing home 0 (0%) 0 (0%) 3 (7.9%) 3 (9.1%)
Rehabilitation hospital 1 (4.8%) 0 (0%) 0 (0%) 0 (0%)
30-day readmission d 1 (4.8%) 5 (12.8%) 6 (15.7%) 5 (45.5%)
1-year Mortality 2 (9.5%) 5 (12.8%) 14 (36.8%) 4 (36.4%)
5-year Mortality 9 (42.9%) 24 (61.5%) 23 (60.5%) 5 (45.4%)

Data are either n (%), mean (SD) or median (IQR) unless otherwise stated.

Abbreviations: O-POSSUM – Oesophago-gastric specific Physiological and Operative Severity Score for the enumeration of Mortality and morbidity. a n=100, b n=80, c n=26, d n=102

Note: VO 2 at AT (ml.kg. -1min -1) predefined risk stratification categories (low risk VO 2 at AT >14ml.kg. -1min -1, medium risk VO 2 at AT 11.0-14.0ml.kg -1.min -1, high-risk VO 2 at AT 8.0-10.9ml.kg -1.min -1, highest risk VO 2 at AT <8.0ml.kg -1.min -1 ).